Critical parameter of burst pressure measurement in development of bypass grafts is highly dependent on methodology used  by Sarkar, Sandip et al.
Critical parameter of burst pressure measurement
in development of bypass grafts is highly
dependent on methodology used
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Background: Because of the low patency rate of currently available vascular bypass grafts, researchers are working towards
the development of alternative bypass grafts, ranging from synthetic prostheses to wholly biologic living grafts. The
philosophy of measurement required by regulatory agencies such as the United States Food and Drug Administration
(FDA) as well as to gain the Conformité Européene (CE) mark is to test above and beyond the limits that would be
expected physiologically. The critical parameter of burst pressure is needed for Conformité Européene (CE) mark or
United States Food and Drug Administration (FDA) approval before clinical trials can proceed. An accurate measurement
of burst pressure in potential porous vascular bypass grafts is, therefore, of utmost importance to ensure adequate
strength on implantation in animals and subsequent clinical use. A wide range of methods to measure burst pressure have
been used. We tested the burst pressure of a new polyurethane-based nanocomposite vascular prosthesis by using different
methods to assess whether the method used affected the results.
Methods: Water was infused at flow rates of 0.2, 50, and 100 mL/min through a syringe pump into latex sleeve–lined
porous prostheses manufactured from a poly(carbonate-urea)urethane nanocomposite incorporating silsesquioxane. At
the lowest infusion rate, the inflation was done with and without a nonporous inner lining sleeve. A pressure transducer
was used to record the peak pressure achieved.
Results: Using a nonporous sleeve resulted in a higher burst pressure (428 mm Hg vs 341 mm Hg) at a flow rate of
0.2 mL/min. A lower infusion rate (0.2 mL/min) produced a lower burst pressure than 50 mL/min (428 mm Hg vs 451
mm Hg). No significant difference was found in burst pressure using infusion rates of 50 mL/min and 100 mL/min.
Conclusions: The use of a nonporous sleeve removes the potential weakness presented by the pores themselves. A
continuous high infusion rate consistently overestimates burst pressure. These methods may not reflect the physiologic
state. Care needs to be taken in interpretation of methodology for burst pressure measurement, and the rate of infusion
should be stated in any description of the method. (J Vasc Surg 2006;44:846-52.)
Clinical Relevance: The poor patency of small-caliber vascular bypass prostheses has stimulated a large body of research
into alternative graft materials. This includes synthetic and, more recently, tissue-engineered hybrid products. Acceptance
for international standards requires demonstration of a rigorous mechanical testing regimen, including graft strength,
which has on the whole involved burst strength measurement. However, the methods used to measure burst strength have
varied with respect to apparatus used and rate of graft inflation. We show that these variables lead to markedly different
results. In particular, fast infusion rates may overestimate the actual burst pressure, leading to a false sense of security.When polytetrafluoroethylene (PTFE) was introduced
as a vascular bypass graft material in 1975 by Impra and
Gore, its burst pressure was assessed to be in the region of
600 mm Hg.1 After its clinical use commenced, however, a
number of cases of aneurysmal dilatation were reported,
leading to an examination and optimization of the sintering
process used during graft manufacture as well as the emer-
gence of externally reinforced PTFE prostheses.
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846Since then, despite the poor long-term patency of
PTFE in small caliber (6 mm) bypass, no suitable alter-
native has been forthcoming. There is, however, an ongo-
ing large volume of research into synthetic materials for
vascular implantation. In terms of mechanical characteris-
tics, the ideal prosthesis would demonstrate similar vis-
coelastic properties to native artery, whilst simultaneously
being able to cope with physiologic blood flow. This latter
is both in terms of absolute pressure and also defatigability
in high-cycle testing.
Segmented polyurethanes are at the forefront of mate-
rial research for potential vascular prostheses2 because of
their combination of elasticity and strength. This is a result
of their dual phase configuration with crystalline hard seg-
ments floating in an amorphous soft segment with virtual
crosslinking, with van der Waal interactions and hydrogen
bonding between the two. Polyurethanes also have a low
inflammatory response in vivo, unlike rubber and tradi-
tional silicone rubbers. At present, however, no polyure-
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prostheses because of their long-term biodegradation, poor
thrombogenicity profile, and the difficulties in producing
polyurethane with the combination of high compliance and
strength.3
Although polyurethanes are elastic, they have high
elastic moduli—the distensibility at the low pressures found
physiologically is low. To increase their distensibility, vari-
ous methods have been used to impart porosity to the
conduit walls. Porosity is also desired to promote graft
healing after implantation by transmural fibrovascular infil-
tration and in vivo endothelialization after implantation,4
with an ideal pore size between 10 m and 45 m5;
however, a very large pore size causes overexuberant fi-
brous infiltration and a loss of elasticity.6 The degree of
porosity required to simulate arterial distensibility in vitro is
high in most cases. Unfortunately, a highly porous graft is
much weaker than its nonporous counterpart; therefore,
careful assessment of burst strength is critical in the
progress of a potential graft through to the phases of in vivo
work and subsequent clinical trial.
Many different methods have been used to measure
burst pressure in tubular conduits. These methods usually
consist of subjecting the grafts to increasing intraluminal
pressure until they burst; however, the rate of pressure
increase, the mechanism used to provide this pressure, and
the interface between the graft and the pressurizing fluid
vary considerably.
We have subjected porous polyurethane grafts to burst
pressure testing using water at varying rates of infusion. We
have also tested burst strength with and without a highly
compliant latex sleeve inside the graft to transmit pressure
to the graft wall. Our aim was to discover whether the
differences in methodology caused any difference in the
results obtained.
MATERIALS AND METHODS
Polymer synthesis. Polycarbonate polyol and trans-
cyclohexanediolisobutyl-silsesquioxane were placed in a
reaction flask equipped with a stirrer and nitrogen. Next,
the mixture was heated to dissolve the nanocage. Meth-
ylene di-isocyanate (MDI) was added and then reacted at
70°C for 90 minutes to form a prepolymer. Then, N,
N-dimethylacetamide (DMAC) was added. Chain exten-
sion of the prepolymer was accomplished by the addition
of ethylenediamine and diethylamine in DMAC. Then,
1-butanol in DMAC was added to the mixture to form a
2% polyhedral oligomeric silsesquioxane-poly (carbon-
ate-urea) urethane (POSS-PCU) solution. All chemicals
and reagents were purchased from Aldrich Limited, Gill-
ingham, UK.
Extrusion of polymer to 5 mm vascular bypass graft.
Porous 5-mm internal diameter conduits with a uniform
wall thickness of 0.3 mm made from nanocomposite poly-
carbonate based polyurethane with POSS reinforcement
were tested.
Burst pressure assessment. A high-pressure syringe
pump (Harvard Apparatus PHD 2000 Programmable,Holliston, Mass) containing freshly deionized water (pH
7.0) was connected via a transducer (Honeywell Compo-
nent No. 22PCCFB6G, Morristown, NJ) to 8-cm lengths
of graft with or without a nonporous latex tube lining. This
was vertically suspended with distal clamping and weighted
to ensure 10% longitudinal stretch. The transducer was
precalibrated by connecting it to a standard clinical sphyg-
momanometer and a voltmeter to record voltage readings
at 0, 100, and 200 mm Hg, from which offset and gain
figures were calculated and entered into a personal com-
puter with bespoke software for recording the pressure at a
sample rate of 10 Hz. The transducer was connected via a
10-volt power source to the personal computer.
Water was expelled from the pump with the graft
unclamped to allow the apparatus to be filled completely,
whilst ensuring all air was eliminated from the apparatus.
The clamp and weight was applied and the water infused at
0.2, 50, and 100 mL/min in those grafts with latex lining.
For the graft without latex inner lining, an initial infusion
rate of 0.2 mL/min was commenced, and this was gradu-
ally increased to take account of the percolation of water
through the wall at high pressure and ensure an increasing
intraluminal pressure. Fig 1 summarizes the different meth-
ods. The infusion was continued until the graft material
burst, and the burst pressure was recorded.
Data collection and statistical analysis. Six grafts
were subjected to each method, and mean  standard
deviations (SD) of burst pressure and flow rate were calcu-
lated. One-way analysis of variance parametric variance
analysis with Tukey post-test analysis was undertaken to
compare the results of the different methods.
RESULTS
Fig 2 shows the burst pressures for each method used.
The statistical summary of comparisons is tabulated in
Table I. The use of a latex inner lining resulted in a signifi-
Fig 1. Summary of the different burst pressure-measuring tech-
niques.cantly increased burst pressure. An infusion rate of 0.2 mL/
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The burst pressure between 0.2 mL/min and 50 mL/min
or 50 mL/min and 100 mL/min was not significantly
different.
Fig 3 shows an example of the percolation of water
through the conduit wall at high pressure when a latex
lining was not used. Fig 4 shows how a peak pressure is
reached before a reduction of pressure occurs, despite
continuing infusion, because of aneurysmal dilatation of
the graft.
DISCUSSION
The conduits tested had an open porous structure. This
interconnected network of pores is a prerequisite for trans-
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Fig 2. Burst pressures obtained via the different measuring tech-
niques. Data are mean SD of six experiments. Keys: *P .001 vs
no latex lining; †P .05 vs 0.2 mL/min; ‡P .05 vs 0.2 mL/min;
§P  .05 vs 50 mL/min.
Table I. The significance of the differences in results
between the four different methods
Method P
No latex lining vs latex lining 0.2 mL/min .001
No latex lining vs latex lining 50 mL/min .001
No latex lining vs latex lining 100 mL/min .001
Latex lining 0.2 mL/min vs latex lining
50 mL/min .05 (NS)
Latex lining 0.2 mL/min vs latex lining
100 mL/min .05
Latex lining 50 mL/min vs latex lining
100 mL/min .05 (NS)
NS, Nonsignificant.mural migration of cells to promote endothelialization.When pressurized, however, the effect is to force water
through the pores, leading to sweating through the graft
wall (see Fig 3). Several consequences follow. First, the rate of
infusion needs to be increased to ensure the intraluminal
pressure continues to increase. Second, the degree of sweating
increases in line with increasing pressure because of the
stretching of the interporous walls. This causes the pores to
increase in size, raising the overall permeability of the wall.
At very high pressures, fracture of the interporous walls
occurs, causing coalescence of pores into larger cavities.
Because of the interconnecting nature of the pores, the
pressure is instantly equalized between adjacent pores. On
coalescence of two pores, this same pressure is, in effect,
exerting stress on a larger balloon. The wall tension in-
creases in proportion to the increased radius as given by
Laplace [T  pr/2], where T represents tension in the
pore wall, p is the change in pressure, and r is pore radius.
This increase in tension makes it likely that the new cavity
will also burst and coalesce into a larger cavity. This mech-
anism eventually leads to the graft bursting.
In practice, blood will interact with the graft wall
differently than water. Its progress through the open pore
network will be impaired because of the larger size of the
particles. This will result in a nonuniform distribution of
pressure across the graft wall. The blood will also leave a
thin layer of clot on the luminal surface, effectively closing
the pore system. This is an argument for using a nonporous
latex sleeve, which tests the strength of the whole wall
thickness; however, porous grafts are now being developed
that are designed to discourage thrombus formation.7 In
addition, thrombus cover may not be uniform, leading to
patches that are vulnerable to pore coalescence.
Graft failure caused by the redistribution of tension
across large cavities due to pore coalescence is analogous
to the mechanism by which Dacron grafts weaken. Da-
cron prostheses consist of knitted or woven fibers. Initial
strength is lost because of the fraying and eventual
breakage of a single fiber. This may be initiated by yarn
slippage within the canvas causing an area of increased
localized stress8 that leads to greater strain on the re-
maining fibers because the same stress is exerted on fewer
fibers.8 The initial fraying of a single fiber by biodegra-
dation9 can occur despite the high crystallinity of Da-
cron, resulting in excellent biostability of the overall
structure. Hence, high burst pressures demonstrated
initially in the laboratory under static testing conditions
may be inaccurate compared with the implanted graft
under high cycle pulsatile flow.
The higher burst pressures obtained when a latex sleeve
is used suggest that the circumferential stress is being
exerted equally across the whole wall rather than being
concentrated through pores. The pore structure may, how-
ever, make a nonporous lining essential because of the rapid
transmural leaking of water. This is especially true for highly
porous structures and less-porous materials that have very
high burst pressures, such as expanded PTFE.
Some groups have tested burst pressures at much
greater rates of pressure increase than here by connecting
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The high infusion rates may be necessary in the methodol-
Fig 3. Subjecting the graft with an interconnected poro
“sweating” of water through the wall.
Fig 4. The aneurysmal point is a more accurate term than burst
pressure, defined as the point atwhich further infusion at the same rate
does not result in any increase in pressure (in this case 347 mmHg).ogy because the porosity allows the gas to escape throughthe graft wall as fast as it is infused. At such high rates, the
time between the development of a flaw and the subse-
quent rupture is almost negligible.
By contrast, we found that slow infusion gradually led
to a point when subsequent continued infusion at that rate
resulted in a reduction in pressure. We recognized this as
the moment at which aneurysmal change was developing,
and at that infusion rate, no further pressure increase would
occur before the graft would burst (Fig 4). We found,
however, that if the rate of infusion was dramatically in-
creased at this “aneurysmal point,” a further increase in
pressure was possible.
In findings similar to ours, McClurken et al10 noted
that a constant infusion of water into a latex balloon that
was lining a PTFE graft, such that the sample burst over
10 to 20 seconds, led to a point where massive dilatation
started to occur, causing a drop in pressure so that the
pressure at the moment the graft actually burst was much
lower than at its peak. Our proposal is that a very high
infusion rate could continue to increase pressure in the
conduit despite the distension, thereby overestimating
burst strength.
A viscoelastic component to the vessel wall properties
also results in different mechanical behavior, depending on
ructure to intraluminal pressure of 300 mm Hg leads tous stthe rate of distension.11 Although previous studies have
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artery, this experiment has not quantified the relative im-
portance of viscosity.
Graft strength is the most fundamental characteristic of
bypass grafts in development; therefore, its accurate mea-
surement is of paramount importance. The philosophy of
measurement required by regulatory agencies such as the
United States Food and Drug Administration (FDA) is to
test above and beyond the limits that would be expected
physiologically. At the same time, the FDA advocates a
“least burdensome approach” to testing, recognizing the
large number of tests required to show graft safety.12 These
two philosophies are demonstrated by the FDA’s approval
of methods that use water or saline rather than blood for
burst pressure testing. In addition, although the difference
Table II. Methods used and results obtained for burst pre
according to Medline search results for the key-term “burs
Graft/Anastomosis Burst pressure testin
Biodegradable polyester scaffold13 PBS via syringe pump
Seeded carotid acellular matrix14 Media perfusion solut
peristaltic pump at
Chitosan-blended polymer membrane-
covered stent15
Saline via syringe pum
Glue adhesive anastomosis16 Saline via hypodermic
Crosslinked acellular porcine carotid17 Distilled water via air 
Heparinized acellular porcine carotid18 Water via syringe pum
Fibronectin tubes19 Growth media via syr
Hemostased ends of explanted porcine
arteries (ultrasound, diathermy and
clips)20
Saline via hypodermic
Solder/laser treated rat femoral artery
aneurysm21
Saline via syringe
Heparinized acellular porcine carotid22 PBS via syringe pump
Cryopreserved de-endothelialized
allograft vein with subsequent
endothelialisation23
‘Fluid’ filled syringe p
Hemostased ends of internal thoracic
artery branches using harmonic
scalpel24
Air via hypodermic sy
Explanted canine carotid25 High pressure nitroge
supply
Porcine splenic artery anastomoses
using protein-based solder26
Syringe driver (fluid u
indicated)
Polyethylene glycol-derived adhesive
on collagen, carotid and PTFE
defects27
Water via syringe driv
Seeded bioabsorbable polymer
scaffolds28
PBS (system not desc
Hybrid polymer/tissue engineered
grafts29
PBS via syringe pump
Microporous polyurethane30 Air pressurized device
Rat femoral artery
anastomosis–sutures, sleeve, laser31
Saline via syringe pum
Protein solder and collagen patch
repair of porcine arteries32
PBS via syringe pump
Diathermy hemostasis of animal
arteries and veins33
Not described
PBS, Phosphate-buffered saline; PTFE, polytetrafluoroethylene.
*Reached limit of apparatus.in results due to different methodology for our grafts didnot place them at risk of bursting in the physiologic range
of blood pressures, the difference is still very important,
because burst pressure is a fair indicator of structure, in-
cluding any flaws, which is intimately related to the long-
term fatigue strength. For this reason, although precise
qualitative guidelines are not given, the FDA is unlikely to
approve synthetic grafts with burst pressures just above the
physiologic range.
Published articles report considerable variation in the
methods used tomeasure burst strength, whichmay lead to
a discrepancy between results and subsequent graft perfor-
mance after implantation. Table II shows the methods
described for reporting burst pressures for vascular grafts
and anastomoses in articles catalogued on Medline within
the last 10 years.13-33 The importance of the method used
testing of tubular conduits within the last 10 years
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phas often been unrecognized, on occasion leading to the
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final result.
CONCLUSION
The use of a latex sleeve increases the burst pressure
obtained. This is due to the pores being negated by the
nonporous sleeve. The mechanism by which graft failure
occurs in vivo may not, however, be through pore coales-
cence because of initial clot formation followed by a con-
fluent neointimal layer. In addition, with highly porous
grafts, it may be very difficult to maintain an increasing
intraluminal pressure because of transmural leakage, leav-
ing no option but to use a nonporous lining.
A high infusion rate overestimates burst pressure. The
discrepancy may be even greater when using the very high
infusion rates associated with gas cylinder pressure, but we
cannot confirm this because our maximum infusion rate
was 100 mL/min.
When burst pressure is measured, the precise method
including infusion fluid, infusion rate and the use of lining
materials needs to be carefully considered and described
when the results are reported. Although the use of blood as
the infusion fluid may be more physiologically realistic, this
reduces the high burden of proof requested by standards
agencies and changes a purely mechanical test into a func-
tional one.
We wish to thank Prof Steve Greenwald, Institute of
Pathology, Queen Mary, University of London for pro-
viding us with the infusion pump and his expertise and
time.
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